Effective 1 July 2022, the following new items and amendments will be made to pathology items, information fact sheets can be found below.

• Six new MBS items will be introduced for genetic testing for heritable kidney disease other than Alport syndrome
• Four new MBS items will be introduced for genetic testing for diagnosis of heritable cardiac arrhythmia disorders and an additional four new MBS items will be introduced for genetic testing for heritable cardiomyopathies
• Four new MBS items will be introduced for genetic testing of alpha thalassaemia
• Four new MBS items will be introduced, and one existing MBS item (73325) will be amended for the expansion of genetic testing for myeloproliferative neoplasms
• Two new MBS items will be introduced for Non-Invasive Prenatal Testing (NIPT) for fetal Rhesus D genotype
• Two existing MBS items (73071 and 73073) will be amended to expand access to self collected tests under the National Cervical Screening Program Self Collection Policy
• Three existing MBS items (73385, 73386 and 73387) for pre implantation genetic testing (PGT) of biopsied embryos will be amended to clarify the policy intent of the services

July 2022 Pathology Fact Sheets

Fact Sheet	PDF and Word versions
Genetic testing for heritable kidney disease other than Alport syndrome – 1 July 2022 (Last Updated: 08 June 2022)	PDF version Genetic testing for heritable kidney disease other than Alport syndrome – 1 July 2022 (PDF 212 KB) Word version Genetic testing for heritable kidney disease other than Alport syndrome – 1 July 2022 (Word 92 KB)
Genetic testing for diagnosis of heritable cardiac arrhythmias, channelopathies and cardiomyopathies – 1 July 2022 (Last Updated: 08 June 2022)	PDF version Genetic testing for diagnosis of heritable cardiac arrhythmias, channelopathies and cardiomyopathies – 1 July 2022 (PDF 217 KB) Word version Genetic testing for diagnosis of heritable cardiac arrhythmias, channelopathies and cardiomyopathies – 1 July 2022 (Word 86 KB)
Genetic testing of alpha thalassaemia – 1 July 2022 (Last Updated: 08 July 2022)	PDF version Genetic testing of alpha thalassaemia – 1 July 2022 (PDF 202 KB) Word version Genetic testing of alpha thalassaemia – 1 July 2022 (Word 89 KB)
Expansion of genetic testing for myeloproliferative neoplasms – 1 July 2022 (Last Updated: 08 June 2022)	PDF version Expansion of genetic testing for myeloproliferative neoplasms – 1 July 2022 (PDF 205 KB) Word version Expansion of genetic testing for myeloproliferative neoplasms – 1 July 2022 (Word 89 KB)
Non-Invasive Prenatal Testing (NIPT) for fetal Rhesus D genotype – 1 July 2022 (Last Updated: 08 June 2022)	PDF version Non-Invasive Prenatal Testing (NIPT) for fetal Rhesus D genotype – 1 July 2022 (PDF 205 KB) Word version Non-Invasive Prenatal Testing (NIPT) for fetal Rhesus D genotype – 1 July 2022 (Word 90 KB)
Improvements to National Cervical Screening Program Self Collection Policy – 1 July 2022 (Last Updated: 08 June 2022)	PDF version Improvements to National Cervical Screening Program Self Collection Policy – 1 July 2022 (PDF 206 KB) Word version Improvements to National Cervical Screening Program Self Collection Policy – 1 July 2022 (Word 90 KB)
Changes to pre implantation genetic testing (PGT) items 73385, 73386 and 73387 – 1 July 2022 (Last Updated: 08 June 2022)	PDF version Changes to pre implantation genetic testing (PGT) items 73385, 73386 and 73387) – 1 July 2022 (PDF 204 KB) Word version Changes to pre implantation genetic testing (PGT) items 73385, 73386 and 73387) – 1 July 2022 (Word 89 KB)